Stryker (SYK) Tops Q4 EPS by 26c

Stryker (NYSE: SYK) reported Q4 EPS of $2.81, $0.26 better than the analyst estimate of $2.55. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.33 billion.

"In spite of COVID-19 outbreaks that intensified through the quarter, our teams showed good resilience and delivered a solid quarter of financial results," said Kevin Lobo, Chairman and Chief Executive Officer. "As we saw with prior pandemic spikes, the impacts were strongest in the businesses linked to deferrable procedures, but as evidenced by our guidance for 2021, we are optimistic about our prospects for the future. The Wright Medical integration is off to a strong start and we continue to advance innovation across the company. On behalf of the Stryker leadership team, I would like to offer my thanks to our employees and to the caregivers and first responders for their efforts in continuing to deal with this health crisis."

GUIDANCE:

Stryker sees FY2021 EPS of $8.80-$9.20. Stryker sees FY2021 revenue of $9.13 billion.

For earnings history and earnings-related data on Stryker (SYK) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Community West Bancshares (CWBC) Tops Q1 EPS by 7c
• Hilltop Holdings (HTH) Tops Q1 EPS by 17c